ERas enhances resistance to CPT-11 in gastric cancer. [electronic resource]
Producer: 20111122Description: 3353-60 p. digitalISSN:- 1791-7530
- Antineoplastic Agents -- pharmacology
- Camptothecin -- analogs & derivatives
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- DNA -- metabolism
- DNA Topoisomerases, Type I -- metabolism
- Drug Resistance, Neoplasm -- drug effects
- Embryonic Stem Cells -- drug effects
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Inhibitory Concentration 50
- Irinotecan
- Models, Biological
- NF-kappa B -- metabolism
- Protein Binding -- drug effects
- Sirolimus -- pharmacology
- Stomach Neoplasms -- drug therapy
- Up-Regulation -- drug effects
- ras Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.